Publicado 13/02/2015 10:28
- Comunicado -

New Data Published in The Lancet Show Daxas® (Roflumilast) Reduces Exacerbations and Hospitalizations in Severe COPD Pat

CONTACT: Contact: Takeda - Danny Stepto: +41-(0)44-555-1504;FleishmanHillard - Andrea Hynes: +44-(0)7912-578-158

Contenido patrocinado